{
  "items": [
    {
      "title": "Johnson & Johnson (NYSE:JNJ) Unveils Promising Prostate Cancer Data With Pasritamig",
      "description": "Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced prostate cancer, which may have influenced its stock's 1.5% rise last week. The study highlights, including a favorable safety profile and potential efficacy in disease control, likely garnered positive investor sentiment. Nevertheless, the company's stock movement is congruent with broader market trends, as the market climbed 1.7% over the same period, likely...",
      "published_utc": "2025-06-03T01:20:01",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=d59436fdb5b748408129dff6b114f16279c1b9c0f1dd375f6cfa24f72ed9d25d",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 134952905,
      "datetime": 1748884801
    },
    {
      "title": "June's Top 10 High-Yield Stocks: Build A Path To A 10%+ Yield By 2035",
      "description": "Discover the top 10 high-yield stocks for June 2025! Learn how to boost income with dividend growth, strong financials, and smart diversification...",
      "published_utc": "2025-06-03T00:00:00",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=1a1690d0d6fa893c1191db6a53ce4c2ce65038e5023a9acbfc5ebed5211df28f",
      "category": "company",
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2156964801/image_2156964801.jpg?io=getty-c-w1536",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 134959783,
      "datetime": 1748880000
    }
  ]
}